🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I am thrilled to share that we extended our collaboration with Servier on an undruggable target in immuno-oncology. This extension follows Servier and Aqemia’s successful partnership program, initiated one year ago in December 2021, to accelerate drug ca…lnkd.in/eNs_Y346

When I think about the strongest research institutes to spin out their tech for outstanding applications and business, one of the obvious (to me 😇) worldwide leaders is Technion - Israel Institute of Technology. 👩‍🔬👨‍🔬 I have the great honour 🙏 to…lnkd.in/e-TFnX3S

😔 The most advanced HIV vaccine under development is being stopped. It does not prevent infections better than a placebo. source: Fierce Biotech's "J&J packs up HIV vaccine after failing phase 3 trial" #biotech #clinicaltrials…lnkd.in/ejJj53Zq lnkd.in/eryBAwBJ

Hello Linkedin 👋, I wanted to spread today’s good news (#hope!) 💪✌️ by Roche and Genentech against the most common type of primary liver cancer, HCC. Today, more than 70% of patients who went through the trauma of an early stag…lnkd.in/ewP49Jnj lnkd.in/eUUVuy6S

Congratulations to Nicolas George, senior medicinal chemist at AQEMIA, who has just received the 2023 SCT Award for young industrial investigator in medicinal chemistry 👏 🚀🚀🚀 I think it is the most prestigious award for medchems under 40 ;) in Franc…lnkd.in/e55A6H8d

Technologies like #generativeAI may have outstanding impact on health, for instance to invent tomorrow's drugs (what we do at AQEMIA), to anticipate cancers or improve #clinicaltrials. 🚀 "if we continue to have the patient at the center, not the techno…lnkd.in/d6J9RM68

"Aqemia making waves in computational drug discovery" That is how Cormac Sheridan titled his recent article in BioWorld about AQEMIA. We discussed with a rare intensity (sincerely, thanks Cormac) about - 👩‍💻 our techno (#gene…lnkd.in/esURJ3Mm lnkd.in/eVruySm7

"Generative AI in a real world environment" I'm eager to discussing about generative AI and its applications in non-academic / business context with Marion Carré from Ask Mona and Olivier Babeau from Institut Sapiens. Thanks Go Entrepreneurs for the oppo…lnkd.in/eFRNpggs

"French champions in generative AI" That's the title of this newspaper article by Maxime Recoquillé in L'Express. 👩‍💻 Hugging Face --> off-the-shelf models 📝 Dust and LightOn ( 👋 Laurent Daudet) --> large language models ✒ i…lnkd.in/eHTaky6U lnkd.in/eYJ7fzjp

I'm very, very proud 😇 to say AQEMIA is laureate of the very first class of the French Tech #health20 😁 French Tech Health20 is the French government program for the 20 most promising startups and scale-ups in #healthtech. French Tech Health20 is ru…lnkd.in/eJP3xaxG

AQEMIA a l'honneur d'être mis en avant par le Gouvernement français pour illustrer la #deeptech, ces startups issue des labo académiques français avec des technologies de rupture (ici #generativeai et physique inspirée du #quantique pour trouver des médi…lnkd.in/eWAuNG3g

AQEMIA is in the news today 😁 Those articles echo AQEMIA's nomination in La French Tech #health20 . -> La Tribune (financial newspaper) -> L'Usine Digitale (numerics and financials newspaper) The urls are in the comments. The illustration? Some musin…lnkd.in/eQijZ47M

This afternoon, I was at the Go Entrepreneurs conference to discuss #generativeAI with 🖼 Marion Carré, cofounder of Ask Mona, a startup doing chat bots for when you visit a museum!, and 👨‍🏫 Olivier Babeau, CEO of Institut Sapiens, a think tank about n…lnkd.in/gRpe7SRZ

I've just read some good news about #alzheimersdisease. 👇 Eli Lilly and Company’s drug candidate against Alzheimer’s disease that is being tested in phase 3 clinical trials seems to slow down the cognitive decline by one third a…lnkd.in/gGXChVBC lnkd.in/gwMihvg4

Ever since I embarked on my journey in drug discovery with Emmanuelle Martiano Rolland, when we co-founded AQEMIA, learning has been a constant part of my daily routine. Some days, it's complex immuno-oncology pathways or business related matters, and on…lnkd.in/ed8gAVTG

Glad to see AQEMIA in this deepdive by the crew (see 👇) at Heartcore Capital . They identified us among the 9 #soonicorn #challenger to beautiful companies and friends I deeply respect : - Exscientia - BenevolentAI - Insilico Medicine - Tempus Labs, Inc…lnkd.in/gyfuJ9Wk

Gearing up for BIO Boston next week! If you're attending and would like to connect over a cup of coffee, don't hesitate to reach out. Looking forward to great conversations and connections. #BIOBoston #drugdiscovery #pharma #vc #generativeai cc Emman…lnkd.in/eEaXeNgy

Hello, you! We're expanding and have several open roles across diverse fields from leadership positions to entry-level opportunities. 🚀🚀🚀 Check out the post by Rania Khassal below! Whether you're a seasoned pro or just starting out, there's a place for…lnkd.in/eJQREsU5

Back to Paris from Boston’s amazing #BIO2023 since last Friday, I’m already in a taxi for the airport - heading to Zurich. AQEMIA is doing really great 🚀🚀🚀 - it is transforming into a global company. Still, even if I’m a vegetarian and ebike for 50…lnkd.in/erMVqUby

AQEMIA 🚀  is laureate of #frenchtech2030, the top-tier selection of startups and scaleups by France Secretary general for investment and La French Tech. We demonstrated healthy growth metrics, technological and industrial maturity, high impact (our int…lnkd.in/ekmszGgf